METHODS
In this study, we reviewed retrospectively 165 patients with
Hodgkin lymphoma. A total of 165 patients were eligible, including
82 female and 83 male patients. The median follow-up
time was 34 (3-139) months.
RESULTS
Five-year overall survival (OS) and disease-free survival
rates for the entire group were 88.5% and 52%, respectively.
In univariate analysis, age (p<0.0001), stage (p<0.005),
Eastern Cooperative Oncology Group (ECOG) performance
status (p<0.0001), B symptoms (p=0.01), serum albumin levels
(p=0.01), and serum lactate dehydrogenase (LDH) levels
(p=0.04) significantly affected OS. Multivariate analysis
showed that only ECOG performance status was an important
prognostic factor for OS (p<0.001).
CONCLUSION
By increasing the number of patients, these results may contribute
to the information about demographical data and treatment
outcomes in patients with Hodgkin lymphoma in our country.
Keywords: Hodgkin lymphoma; prognostic factor
